LJ10 LLC 4
4 · Pear Therapeutics, Inc. · Filed Dec 6, 2021
Insider Transaction Report
Form 4
LJ10 LLC
Other
Transactions
- Conversion
Class B Common Stock
2021-12-03−6,540,000→ 0 total→ Common Stock - Other
Private Placement Warrants
2021-12-03$1.50/sh+5,013,333$7,520,000→ 5,013,333 totalExercise: $11.50→ Common Stock (5,013,333 underlying) - Conversion
Common Stock
2021-12-03+6,540,000→ 6,540,000 total
Footnotes (2)
- [F1]In connection with the consummation of the business combination between Thimble Point Acquisition Corp. ("THMA" and the former name of the Issuer) and Pear Therapeutics, Inc. on December 3, 2021 (the "Closing Date"), the Reporting Person's shares of THMA Class B Common Stock were automatically converted into shares of the Issuer's Common Stock on a one-for-one basis.
- [F2]The private placement warrants were purchased by the Reporting Person in connection with THMA's initial public offering on February 1, 2021. Each private placement warrant is exercisable to purchase one share of Common Stock at a price of $11.50 per share, subject to adjustment, beginning on February 4, 2022 and expires on December 3, 2026 or earlier upon redemption or liquidation.